Skip to main navigation Skip to search Skip to main content

Efficacy of non-invasive brain stimulation interventions in reducing smoking frequency in patients with nicotine dependence: a systematic review and network meta-analysis of randomized controlled trials

  • Ping Tao Tseng
  • , Jia Shyun Jeng
  • , Bing Syuan Zeng
  • , Brendon Stubbs
  • , Andre F. Carvalho
  • , Andre R. Brunoni
  • , Kuan Pin Su
  • , Yu Kang Tu
  • , Yi Cheng Wu
  • , Tien Yu Chen
  • , Pao Yen Lin
  • , Chih Sung Liang
  • , Chih Wei Hsu
  • , Yen Wen Chen
  • , Cheng Ta Li*
  • *Corresponding author for this work
  • Prospect Clinic for Otorhinolaryngology & Neurology
  • National Sun Yat-sen University
  • Asia University Taiwan
  • Veterans General Hospital-Taipei
  • I-Shou University
  • King's College London
  • South London and Maudsley NHS Foundation Trust
  • Anglia Ruskin University
  • Deakin University
  • Universidade de São Paulo
  • China Medical University Taichung
  • National Taiwan University
  • Landseed Hospital
  • Triservice General Hospital Taiwan
  • National Defense Medical University
  • National Yang Ming Chiao Tung University
  • Chang Gung University
  • National Central University

Research output: Contribution to journal › Review article › peer-review

40 Scopus citations

Abstract

Background and aims: Nicotine is a highly addictive substance in tobacco products that dysregulates several neurotransmitters in the brain and impairs executive function. Non-invasive brain stimulation (NIBS) methods such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) are promising treatments for nicotine dependence. We investigated the efficacy and acceptability of NIBS in managing smoking cessation through a systematic review and network meta-analysis (NMA). Methods: We conducted a systematic review to identify randomized controlled trials (RCTs) that investigated the efficacy of NIBS for smoking cessation. All pairwise meta-analyses and NMA procedures were conducted using random-effects and frequentist models. The co-primary outcomes were (1) the change in number of cigarettes smoked per day (change in frequency of smoking) in patients with nicotine dependence after NIBS and (2) acceptability (the dropout rate). The effect sizes for co-primary outcomes of change in frequency of smoking and acceptability were assessed according to standardized mean difference (SMD) and odds ratio, respectively. Results: Twelve RCTs with 710 participants (mean age: 44.2 years, 31.2% female) were included. Compared with the sham control, 10-Hz rTMS over the left dorsolateral prefrontal cortex (DLPFC) was associated with the largest changes in smoking frequency [SMD = −1.22, 95% confidence interval (95% CI) = −1.77 to −0.66]. The 2-mA bifrontal tDCS (SMD = −0.97, 95% CI = −1.32 to −0.62) and 10-Hz deep rTMS over the bilateral DLPFC with cue provocation (SMD = −0.77, 95% CI = −1.20 to −0.34) were associated with a significantly larger decrease in smoking frequency versus the sham. None of the investigated NIBSs was associated with dropout rates significantly different from those of the sham control groups. Conclusion: Prefrontal non-invasive brain stimulation interventions appear to reduce the number of cigarettes smoked with good acceptability.

Original languageEnglish
Pages (from-to)1830-1842
Number of pages13
JournalAddiction
Volume117
Issue number7
DOIs
StatePublished - 07 2022

Bibliographical note

Publisher Copyright:
© 2021 Society for the Study of Addiction.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Benefit
  • network meta-analysis
  • nicotine dependence
  • non-invasive brain stimulation
  • safety
  • smoke cessation

Fingerprint

Dive into the research topics of 'Efficacy of non-invasive brain stimulation interventions in reducing smoking frequency in patients with nicotine dependence: a systematic review and network meta-analysis of randomized controlled trials'. Together they form a unique fingerprint.

Cite this